Cargando…

Impact of early home psychotropic medication reinitiation on surrogate measures of intensive care unit delirium

INTRODUCTION: Intensive care unit (ICU) delirium is a major contributing factor to increased mortality, length of stay, and cost of care. Psychotropic medications may often require extensive tapering to prevent withdrawal symptoms; during ICU admission, home psychotropics are frequently held which m...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Matthew, Chang, Mei H., Miranda-Valdes, Yeismel, Vest, Kirsten, Kish, Troy D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: College of Psychiatric & Neurologic Pharmacists 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607949/
https://www.ncbi.nlm.nih.gov/pubmed/31293845
http://dx.doi.org/10.9740/mhc.2019.07.263
_version_ 1783432175348088832
author Li, Matthew
Chang, Mei H.
Miranda-Valdes, Yeismel
Vest, Kirsten
Kish, Troy D.
author_facet Li, Matthew
Chang, Mei H.
Miranda-Valdes, Yeismel
Vest, Kirsten
Kish, Troy D.
author_sort Li, Matthew
collection PubMed
description INTRODUCTION: Intensive care unit (ICU) delirium is a major contributing factor to increased mortality, length of stay, and cost of care. Psychotropic medications may often require extensive tapering to prevent withdrawal symptoms; during ICU admission, home psychotropics are frequently held which may precipitate acute drug withdrawal and subsequent delirium. METHODS: This is a single-center, observational, retrospective chart review. The primary endpoint was the total number of new-start antipsychotics used to treat ICU delirium. Secondary endpoints included use of restraints, ICU length of stay, and hospital length of stay. RESULTS: A total of 2334 charts were reviewed for inclusion; 55 patients were categorized into each group. There was no statistically significant difference in the requirement for new-start antipsychotics (P = 1.0), restraint use (P = .057), or ICU length of stay (P = .71). There was a statistically significant decrease in hospital length of stay (P = .048). DISCUSSION: Early reinitiation was associated with a decrease in hospital length of stay but was not associated with a decrease in the number of new-start antipsychotics, use of restraints, or ICU length of stay.
format Online
Article
Text
id pubmed-6607949
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher College of Psychiatric & Neurologic Pharmacists
record_format MEDLINE/PubMed
spelling pubmed-66079492019-07-10 Impact of early home psychotropic medication reinitiation on surrogate measures of intensive care unit delirium Li, Matthew Chang, Mei H. Miranda-Valdes, Yeismel Vest, Kirsten Kish, Troy D. Ment Health Clin Original Research INTRODUCTION: Intensive care unit (ICU) delirium is a major contributing factor to increased mortality, length of stay, and cost of care. Psychotropic medications may often require extensive tapering to prevent withdrawal symptoms; during ICU admission, home psychotropics are frequently held which may precipitate acute drug withdrawal and subsequent delirium. METHODS: This is a single-center, observational, retrospective chart review. The primary endpoint was the total number of new-start antipsychotics used to treat ICU delirium. Secondary endpoints included use of restraints, ICU length of stay, and hospital length of stay. RESULTS: A total of 2334 charts were reviewed for inclusion; 55 patients were categorized into each group. There was no statistically significant difference in the requirement for new-start antipsychotics (P = 1.0), restraint use (P = .057), or ICU length of stay (P = .71). There was a statistically significant decrease in hospital length of stay (P = .048). DISCUSSION: Early reinitiation was associated with a decrease in hospital length of stay but was not associated with a decrease in the number of new-start antipsychotics, use of restraints, or ICU length of stay. College of Psychiatric & Neurologic Pharmacists 2019-07-01 /pmc/articles/PMC6607949/ /pubmed/31293845 http://dx.doi.org/10.9740/mhc.2019.07.263 Text en © 2019 CPNP. The Mental Health Clinician is a publication of the College of Psychiatric and Neurologic Pharmacists. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Li, Matthew
Chang, Mei H.
Miranda-Valdes, Yeismel
Vest, Kirsten
Kish, Troy D.
Impact of early home psychotropic medication reinitiation on surrogate measures of intensive care unit delirium
title Impact of early home psychotropic medication reinitiation on surrogate measures of intensive care unit delirium
title_full Impact of early home psychotropic medication reinitiation on surrogate measures of intensive care unit delirium
title_fullStr Impact of early home psychotropic medication reinitiation on surrogate measures of intensive care unit delirium
title_full_unstemmed Impact of early home psychotropic medication reinitiation on surrogate measures of intensive care unit delirium
title_short Impact of early home psychotropic medication reinitiation on surrogate measures of intensive care unit delirium
title_sort impact of early home psychotropic medication reinitiation on surrogate measures of intensive care unit delirium
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607949/
https://www.ncbi.nlm.nih.gov/pubmed/31293845
http://dx.doi.org/10.9740/mhc.2019.07.263
work_keys_str_mv AT limatthew impactofearlyhomepsychotropicmedicationreinitiationonsurrogatemeasuresofintensivecareunitdelirium
AT changmeih impactofearlyhomepsychotropicmedicationreinitiationonsurrogatemeasuresofintensivecareunitdelirium
AT mirandavaldesyeismel impactofearlyhomepsychotropicmedicationreinitiationonsurrogatemeasuresofintensivecareunitdelirium
AT vestkirsten impactofearlyhomepsychotropicmedicationreinitiationonsurrogatemeasuresofintensivecareunitdelirium
AT kishtroyd impactofearlyhomepsychotropicmedicationreinitiationonsurrogatemeasuresofintensivecareunitdelirium